文献速递肝胆胰外科胃肠外科

肝胆道原发性胃泌素瘤的发病率与预后

Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract.
PubMed 文献 · JAMA Surg · 2018-01-01

该研究纳入223例在NIH和斯坦福大学医院接受手术的Zollinger-Ellison综合征患者,其中7例(3.1%)为肝胆道原发性胃泌素瘤。这些肿瘤可发生于胃泌素瘤三角外,需积极行肝或胆道切除及区域淋巴结清扫,长期治愈率和生存率较高,并发症可接受。

要点

  • 肝胆道原发性胃泌素瘤占3.1%,是十二指肠胰腺外第二常见原发部位。
  • 肿瘤可位于胃泌素瘤三角外,发现后需改变手术方式。
  • 应行积极肝或胆道切除并常规清扫肝门淋巴结。

核心结论

  • 肝胆道原发性胃泌素瘤不常见(3%),但为十二指肠胰腺外第二常见原发部位(仅次于淋巴结)。
  • 发现此类肿瘤需行积极肝或胆道切除,长期治愈率和生存率高,并发症可接受。
  • 因近50%患者有淋巴结转移,应常规切除肝门淋巴结。

研究设计与样本

  • 前瞻性方案纳入1982年6月至2017年8月NIH和斯坦福大学医院223例 consecutive 接受手术的Zollinger-Ellison综合征患者。
  • 采用质子泵抑制剂控制胃酸高分泌,手术切除肿瘤。

主要发现

  • 223例手术患者中7例(3.1%)有肝或胆道原发肿瘤,包括5男2女,诊断时平均年龄43岁(范围27-54岁)。
  • 平均血清胃泌素水平817 pg/mL(范围289-2700 pg/mL),每例促胰液素试验均阳性,无MEN1证据。
  • 4例原发肿瘤在肝(II段1例、IV段2例、V段1例),3例在胆管(右肝管、左肝管、肝总管各1例)。
  • 4例有淋巴结转移,无远处转移;无手术死亡,3例出现并发症(胆管狭窄、门静脉狭窄、胆瘘)。
  • 术后近期均无病,3例分别于3、11、15年复发于肝和门淋巴结;3例(43%)随访24个月至26年无病。

关键数值与推荐

  • 治愈定义为血清胃泌素水平在参考范围内、促胰液素试验阴性、影像学未见肿瘤。

临床怎么用

  • 对Zollinger-Ellison综合征患者应考虑到肝胆道原发胃泌素瘤可能,尤其位于胃泌素瘤三角外时。
  • 发现肝胆道原发胃泌素瘤应行积极肝或胆道切除,并常规清扫肝门淋巴结。

局限性

  • 样本量小(7例肝胆道原发肿瘤),来自单中心前瞻性方案,结论需谨慎推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Zollinger-Ellison syndrome (ZES) is a life-threatening disease caused by a malignant tumor that secretes gastrin (gastrinoma). Gastrinomas typically occur in the pancreas or the duodenum. OBJECTIVE: To describe the incidence and prognosis of very unusual gastrinomas originating in the hepatobiliary tract. DESIGN, SETTING, AND PARTICIPANTS: This study included 223 consecutive patients at the National Institutes of Health and Stanford University Hospital who were enrolled in a prospective protocol to treat ZES using proton pump inhibitors to control acid hypersecretion and surgical resection to ameliorate the tumoral process. Data were collected from June 1982 to August 2017. MAIN OUTCOMES AND MEASURES: Incidence, location, surgical results, and cure rate and overall survival among patients with gastrinomas that originate in the liver or bile ducts. Cure was defined as serum gastrin levels within the reference range, negative results of a secretin test, and no tumor found on imaging. RESULTS: Of the 223 patients who underwent surgery to remove gastrinomas, 7 (3.1%) had liver or biliary tract primary tumors, including 5 men and 2 women (mean age at diagnosis, 43 years; range 27-54 years). The mean serum gastrin level was 817 pg/mL (range, 289-2700 pg/mL). Each patient had positive results of a secretin test. None had evidence of multiple endocrine neoplasia 1. Four patients had primary tumors in the liver (1 in segment II, 2 in segment IV, and 1 in segment V); 3, in the bile duct (1 in the right hepatic duct, 1 in the left hepatic duct, and 1 in the common hepatic duct). Surgical resection required 1 right hepatic lobectomy, 1 left lateral segmentectomy, 2 left hepatic lobectomies, 1 central hepatectomy, and 2 bile duct resections. Four patients had nodal metastases, and no patient had distant metastases. No operative deaths occurred, but 3 patients had complications, including bile duct stricture, portal vein stricture, and biliary fistula. Each patient was disease free in the immediate postoperative period, and 3 had recurrences in the liver and portal lymph nodes (at 3, 11, and 15 years). Three patients (43%) remained free of disease at follow-up ranging from 24 months to 26 years. CONCLUSIONS AND RELEVANCE: Primary gastrinomas of the hepatobiliary tract are uncommon (3%), but the hepatobiliary system is the second most frequent extraduodenopancreatic primary location (after the lymph nodes). These tumors can occur outside the gastrinoma triangle and must be specifically considered. Furthermore, their discovery changes the operative approach because aggressive liver or bile duct resection is indicated, with high rates of long-term cure and survival and acceptable rates of complications. In addition, their discovery dictates that lymph nodes in the porta hepatis should be routinely excised because nearly 50% of patients will have lymph node metastases. This study investigates the incidence and prognosis of gastrinomas originating in the hepatobiliary tract in patients with Zollinger-Ellison syndrome. QUESTION: Do primary gastrinomas of the liver exist? FINDINGS: In this series of 223 patients with Zollinger-Ellison syndrome, primary gastrinomas of the liver were the second most common extrapancreatic, extraintestinal site for a primary gastrinoma and may metastasize to regional lymph nodes. Aggressive resection is indicated because cure rates and survival are similar to those for primary gastrinomas in other locations. MEANING: Liver primary gastrinomas occur and warrant aggressive resection including regional lymph nodes.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Norton JA, Foster DS, Blumgart LH, et al. Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract. JAMA Surg. 2018. PMID: 29365025. doi:10.1001/jamasurg.2017.5083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。